Survival of blacks and whites after a cancer diagnosis

JAMA

Volumn 287, Issue 16, 2002, Pages 2106-2113

  Bach, Peter B ^a,b   Schrag, Deborah ^a,b   Brawley, Otis W ^d   Galaznik, Aaron ^c   Yakren, Sofia ^a   Begg, Colin B ^a  

^a Health Outcomes Research Group   (United States)

^b Department of Medicine ^*  (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER SURVIVAL; CAUCASIAN; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; ETHNIC DIFFERENCE; FEMALE; HUMAN; MALE; MEDLINE; META ANALYSIS; MORTALITY; NEGRO; OUTCOMES RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; STATISTICAL ANALYSIS; SURVIVAL RATE; UTERUS CANCER;

EID: 0037165713     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.16.2106     Document Type: Article

References (104)

1. Racial differences in colorectal cancer mortality: The importance of stage and socioeconomic status
2. Black-white differences in stage-specific cancer survival: Analysis of seven selected sites
3. Factors associated with survival differences between black women and white women with cancer of the uterine corpus
4. A collaborative study of differences in the survival rates of black patients and white patients with cancer
5. Racial differences in endometrial cancer survival: The black/white cancer survival study
6. Racial differences in survival from breast cancer: Results of the National Cancer Institute Black/White Cancer Survival Study
7. The relationship of socio-economic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute Black-White Cancer Survival Study
8. Histological characteristics of breast carcinoma in blacks and whites
9. Black and white differences: Narrowing the gap in cancer medicine
10. Racial differences in the androgen/androgen receptor pathway in prostate cancer
11. Racial and ethnic factors in the genetic pathogenesis of colorectal cancer
12. Breast cancer in blacks spurs hunt for answers
13. The meaning of race in science: Considerations for cancer research
14. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993: The perspective of NIH clinical trials
15. Evaluation of priority setting and programs of research on ethnic minority and medically underserved populations at the National Institutes of Health
16. Racial and ethnic disparities in the receipt of cancer treatment
17. Treatment plans for black and white women with stage II nodepositive breast cancer
18. Differences in initial treatment patterns and outcomes of lung cancer in the elderly
19. Treatment modality and quality differences for black and white breastcancer patients treated in community hospitals
20. Medicare treatment differences for blacks and whites
21. Trends and black/white differences in treatment for nonmetastatic prostate cancer
22. Race and outcomes: Is this the end of the beginning for minority health research?
23. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system
24. Racial differences in the treatment of early-stage lung cancer
25. Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: Findings from the National Surgical Adjuvant Breast and Bowel Project
26. Is race an independent prognostic factor for survival from prostate cancer?
27. Race and survival from breast cancer: Based on Cancer and Leukemia Group B trial 8541
28. Socioeconomic status and cancer survival
29. Racial differences in survival from gynecologic cancer
30. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer
31. Comorbidity and breast cancer survival: A comparison between black and white women
32. Long-term survival and prognostic factors in breast cancer patients with localized (no skin, muscle, or chest wall attachment) disease with and without positive lymph nodes
33. The effect of comorbidity on 3-year survival of women with primary breast cancer
34. Race and cause specific survival with prostate cancer: Influence of clinical stage, Gleason score, age and treatment
35. Survival in blacks and whites after treatment for localized prostate cancer
36. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas
37. Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas
38. The prognostic significance of race and survival from breast cancer: A model for assessing the reliability of reported survival differences
39. Extracting summary statistics to perform meta-analyses of the published literature for survival end points
40. The value of the aggregate data approach in meta-analysis with time-to-event outcomes
41. Meta-analysis in clinical trials
42. Operating characteristics of a rank correlation test for publication bias
43. Racial comparison of outcomes of male Department of Veterans Affairs patients with lung and colon cancer
44. Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer
45. Social factors, treatment, and survival in early-stage nonsmall cell lung cancer
46. Racial and socioeconomic factors in cancer survival
47. Determinants of black/white differences in colon cancer survival
48. Association of African-American ethnic background with survival in men with metastatic prostate cancer
49. Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues
50. The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985)
51. Leuprolide with and without flutamide in advanced prostate cancer
52. The influence of race on the efficacy of curative radiation therapy for carcinoma of the prostate
53. Carcinoma of the prostate: Race as a prognostic indicator in definitive radiation therapy
54. Prostate cancer: Are racial differences in clinical stage and survival explained by differences in symptoms?
55. Age-race interaction in prostatic adenocarcinoma treated with external beam irradiation
56. Prostate cancer in African-American men: Outcome following radiation therapy with or without adjuvant androgen ablation
57. Mortality in prostate cancer
58. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system
59. Race, prostate cancer survival, and membership in a large health maintenance organization
60. Removal of the financial barrier to health care: Does it impact on prostate cancer at presentation and survival?
61. Stage at presentation and survival of white and black patients with prostate carcinoma
62. Prognosis among African-American women and white women with lymph node negative breast carcinoma: Findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)
63. A comparison of treatment outcomes for black patients and white patients with metastatic breast cancer
64. Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation
65. Prognostic factors in inflammatory breast cancer: Univariate and multivariate analysis
66. Disaggregating the effects of race on breast cancer survival
67. Effects of race and socioeconomic status on survival of 1,332 black, Hispanic, and white women with breast cancer
68. Breast cancer: Is ethnicity an independent prognostic factor for survival?
69. Conservative surgery and radiation therapy in black women with early stage breast cancer
70. Effects of health insurance and race on breast carcinoma treatments and outcomes
71. Racial differences in breast cancer survival: The effect of residual disease
72. Race and differences in breast cancer survival in a managed care population
73. Breast carcinoma survival analysis for African American and white women in an equal-access health care system
74. Race, income, and survival from breast cancer at two public hospitals
75. Delay, stage of disease, and survival among white and black women with breast cancer
76. Radiation therapy for esophageal cancer: The Medical College of Virginia experience
77. Evaluation of race as a prognostic factor in multiple myeloma
78. Race, poverty, and survival in multiple myeloma
79. Factors contributing to the poorer survival of black Americans diagnosed with oral cancer (United States)
80. Race and gender influences on the survival of patients with mouth cancer
81. The prognostic significance of race and survival from laryngeal carcinoma
82. Racial differences in surgically staged patients with endometrial cancer
83. Race and prognosis of brain tumor patients entering multicenter clinical trials
84. Comparison of clinical outcome in black and white women treated with radiotherapy for cervical carcinoma
85. Differences in cervical cancer mortality among black and white women
86. Equal care ensures equal survival for African-American women with cervical carcinoma
87. Cervical cancer survival in a high risk urban population
88. Osteogenic sarcoma in the American black
89. Estimates of lead time and length bias in a breast cancer screening program
90. The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer
91. Breast cancer: Factors associated with stage at diagnosis in black and white women
92. Benign tumors and early detection in mammography-screened patients of a natural cohort with breast cancer
93. Progress in cancer screening over a decade: Results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys
94. Noncancer deaths in white adult cancer patients